Clinical trial
The Leadless AV Versus DDD Pacing Study: A Randomized Controlled Single-center Trial on Leadless Versus Conventional Cardiac Dual-chamber Pacing
NCT05498376 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Leadless AV Versus DDD Pacing Study: A Randomized Controlled Single-center Trial on Leadless Versus Conventional Cardiac Dual-chamber Pacing
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- August 23, 2022
- Completion date
- December 31, 2027
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arrhythmias, cardiac, cardiac pacemaker, cardiovascular diseases, heart diseases